Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Perarnau, A. Gouge, Charlotte Nicolas, L. D’alteroche, P. Borentain, F. Saliba, A. Minello, R. Anty, C. Chagneau-Derrode, P. Bernard, A. Abergel, I. Ollivier-Hourmand, J. Gournay, J. Ayoub, C. Gaborit, E. Rusch, B. Giraudeau (2014)
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.Journal of hepatology, 60 5
N. Procaccini, A. Al-Osaimi, P. Northup, C. Argo, S. Caldwell (2009)
Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis.Gastrointestinal endoscopy, 70 5
R. Bañares, A. Albillos, D. Rincón, S. Alonso, Mónica González, L. Ruíz‐del‐Árbol, M. Salcedo, Luis-Miguel Molinero (2002)
Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta‐analysisHepatology, 35
JM Perarnau, A Guge, C Nicolas (2014)
Covered vsuncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol, 60
M. Rudler, P. Cluzel, T. Corvec, H. Benosman, G. Rousseau, T. Poynard, D. Thabut (2014)
Early‐TIPSS placement prevents rebleeding in high‐risk patients with variceal bleeding, without improving survivalAlimentary Pharmacology & Therapeutics, 40
J. Cello, E. Ring, E. Olcott, J. Koch, R. Gordon, J. Sandhu, D. Morgan, J. Ostroff, D. Rockey, P. Bacchetti, J. Laberge, J. Lake, K. Somberg, Catherine Doherty, M. Davila, K. Mcquaid, S. Wall (1997)
Endoscopic Sclerotherapy Compared with Percutaneous Transjugular Intrahepatic Portosystemic Shunt after Initial Sclerotherapy in Patients with Acute Variceal HemorrhageAnnals of Internal Medicine, 126
R. Jalan, K. Bzeizi, D. Tripathi, H. Lui, D. Redhead, P. Hayes (2002)
Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year periodEuropean Journal of Gastroenterology & Hepatology, 14
R. Lindor, K. Lindor (2011)
The value of observational research in liver diseasesHepatology, 53
P Sauer, J Hansmann, GM Richter (2002)
Endoscopic variceal ligation plus propranolol vstransjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy, 34
A Monescillo, F Martinez-Lagares, L Ruiz-del-Arbol (2004)
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleedingHepatology, 40
Roberto Franchis (2005)
Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.Journal of hepatology, 53 4
J. García‐Pagán, K. Caca, C. Bureau, W. Laleman, B. Appenrodt, A. Luca, J. Abraldes, F. Nevens, J. Vinel, J. Mössner, J. Bosch (2010)
Early use of TIPS in patients with cirrhosis and variceal bleeding.The New England journal of medicine, 362 25
G. Pomier‐Layrargues, J. Villeneuve, M. Deschênes, B. Bui, P. Perreault, D. Fenyves, B. Willems, D. Marleau, M. Bilodeau, M. Lafortune, Dufresne Mp (2001)
Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trialGut, 48
T. Boyer, Z. Haskal (2005)
The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertensionHepatology, 41
T. Sauerbruch, M. Mengel, M. Dollinger, A. Zipprich, M. Rössle, E. Panther, R. Wiest, K. Caca, A. Hoffmeister, H. Lutz, R. Schoo, H. Lorenzen, J. Trebicka, B. Appenrodt, M. Schepke, R. Fimmers (2015)
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.Gastroenterology, 149 3
M. Rössle, P. Deibert, K. Haag, A. Ochs, M. Olchewski, V. Siegerstetter, K. Hauenstein, R. Geiger, C. Stiepak, W. Keller, H. Blum (1997)
Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleedingThe Lancet, 349
G. Lo, H. Liang, W-C Chen, M-H Chen, K. Lai, P. Hsu, C.‐K. Lin, H. Chan, H. Pan (2007)
A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.Endoscopy, 39 8
Aberto Monescillo, ez-Lagares, Angel Sierra, C. Guevara, Elena JitnGnez, Jos, Miguel Marrero, Enrique Buceta, Juan Shchez, A. Castellot, Mhica PeGate, Elena Pefia (2005)
LIVER FAILURE AND LIVER DISEASE
I. Holster, E. Tjwa, A. Moelker, A. Wils, B. Hansen, J. Vermeijden, P. Scholten, B. Hoek, J. Nicolai, E. Kuipers, P. Pattynama, H. Buuren (2016)
Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β‐blocker for prevention of variceal rebleedingHepatology, 63
AJ Sanyal, AM Freedman, VA Luketic (1997)
Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhageA randomized, controlled trial. Ann Intern Med, 126
M. Merli, F. Salerno, O. Riggio, R. Franchis, F. Fiaccadori, P. Meddi, M. Primignani, G. Pedretti, A. Maggi, L. Capocaccia, A. Lovaria, U. Ugolotti, F. Salvatori, M. Bezzi, P. Rossi (1998)
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trialHepatology, 27
P. Sauer, J. Hansmann, G. Richter, W. Stremmel, A. Stiehl (2002)
Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.Endoscopy, 34 9
F. Salerno, C. Cammà, M. Enea, M. Rössle, F. Wong (2007)
Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.Gastroenterology, 133 3
H. Xue, Meng Zhang, J. Pang, Fei Yan, Ying-Chao Li, Liangshan Lv, Jia Yuan, M. Palikhe, Wei-zhi Li, Zhi-Lun Wang (2012)
Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.World journal of gastroenterology, 18 48
NJ Procaccini, AM Al-Osaimi, P Northup (2009)
Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.Sanalysis. GastroIntest Endosc, 70
GS Kochhar, U Navaneethan, J Hartman (2015)
Comparative study of endoscopy vstransjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding. Gastroenterol Rep (Oxf), 3
A. Sanyal, A. Freedman, V. Luketic, Preston III, M. Shiffman, P. Cole, J. Tisnado, S. Simmons (1997)
Transjugular Intrahepatic Portosystemic Shunts Compared with Endoscopic Sclerotherapy for the Prevention of Recurrent Variceal HemorrhageAnnals of Internal Medicine, 126
J. García‐Pagán, M. Pascoli, K. Caca, W. Laleman, C. Bureau, B. Appenrodt, A. Luca, A. Zipprich, J. Abraldes, F. Nevens, J. Vinel, T. Sauerbruch, J. Bosch (2012)
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study.Journal of hepatology, 58 1
G. Garcia‐Tsao, A. Sanyal, N. Grace, W. Carey (2007)
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in CirrhosisThe American Journal of Gastroenterology, 102
L. García‐Villarreal, Francisco Martínez‐Lagares, Angel Sierra, C. Guevara, J. Marrero, E. Jiménez, A. Monescillo, Teresa Hernández‐Cabrero, J. Alonso, R. Fuentes (1999)
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhageHepatology, 29
R. Jalan, E. Forrest, A. Stanley, D. Redhead, J. Forbes, J. Dillon, A. MacGilchrist, N. Finlayson, P. Hayes (1997)
A randomized trial comparing transjugular intrahepatic portosystemic stent‐shunt with variceal band ligation in the prevention of rebleeding from esophageal varicesHepatology, 26
Veit Gülberg, M. Schepke, G. Geigenberger, Jane Holl, K. Brensing, T. Waggershauser, M. Reiser, H. Schild, Tilman Sauerbruch, A. Gerbes (2002)
Transjugular Intrahepatic Portosystemic Shunting is not Superior to Endoscopic Variceal Band Ligation for Prevention of Variceal Rebleeding in Cirrhotic Patients: a Randomized, Controlled TrialScandinavian Journal of Gastroenterology, 37
Y. Narahara, H. Kanazawa, H. Kawamata, N. Tada, H. Saitoh, S. Matsuzaka, Y. Osada, Y. Mamiya, K. Nakatsuka, H. Yoshimoto, Nobuhito Koizumi, C. Sakamoto, Masafumi Kobayashi (2001)
A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage.Hepatology research : the official journal of the Japan Society of Hepatology, 21 3
JP Cello, EJ Ring, EW Olcott (1997)
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhageA randomized, controlled trial. Ann Intern Med, 126
G. Kochhar, U. Navaneethan, J. Hartman, Jose Parungao, R. Lopez, Ranjan Gupta, Baljendra Kapoor, Paresh Mehta, M. Sanaka (2015)
Comparative study of endoscopy vs. transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleedingGastroenterology Report, 3
M. Rössle (2013)
TIPS: 25 years later.Journal of hepatology, 59 5
P. Sauer, L. Theilmann, W. Stremmel, C. Benz, G. Richter, A. Stiehl (1997)
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.Gastroenterology, 113 5
G. Wells, G. Wells, B. Shea, B. Shea, Dianne O'Connell, J. Peterson, Welch, M. Losos, P. Tugwell, Sb Ga, G. Zello, J. Petersen (2014)
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
P. Popovič, B. Štabuc, P. Skok, M. Šurlan (2010)
Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Sclerotherapy in the Elective Treatment of Recurrent Variceal BleedingJournal of International Medical Research, 38
Zhiping Yang, G. Han, Qiong Wu, X. Ye, Zhichao Jin, Z. Yin, X. Qi, M. Bai, Kaichun Wu, D. Fan (2010)
Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene‐covered stents versus bare stents: A meta‐analysisJournal of Gastroenterology and Hepatology, 25
J. Cabrera, M. Maynar, R. Granados, E. Górriz, R. Reyes, J. Pulido-Duque, JL SanRoman, Carmen Guerra, D. Kravetz (1996)
Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.Gastroenterology, 110 3
L. Casadaban, A. Parvinian, J. Minocha, J. Lakhoo, Christopher Grant, Charles Ray, M. Knuttinen, J. Bui, R. Gaba (2015)
Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical OutcomesDigestive Diseases and Sciences, 60
M. Zheng, Yongping Chen, J. Bai, Q. Zeng, J. You, Rong Jin, Xiaoping Zhou, H. Shen, Yi Zheng, Zhou Du (2008)
Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Therapy in the Secondary Prophylaxis of Variceal Rebleeding in Cirrhotic Patients: Meta-analysis UpdateJournal of Clinical Gastroenterology, 42
Endoscopic therapy (ET) is most common method for preventing variceal bleeding in cirrhosis, but the outcomes are not perfect. Recently, transjugular intrahepatic portosystemic shunt (TIPS) is introduced into clinical practice. However, the beneficial effects of TIPS compared to ET on cirrhotic patients is unknown. The aim of this study was to evaluate and compare the effects of TIPS with those of the most frequently used ET for prevention of variceal rebleeding (VRB) in liver cirrhosis. The Pub-Med, EMBASE, and Cochrane Library databases were searched from inception to February 2017. The primary study outcomes included the incidence of VRB, all-cause mortality, bleeding-related death, and the incidence of post-treatment hepatic encephalopathy (PTE). The odds ratios (ORs) with 95% confidence intervals (CI) were pooled for dichotomous variables. Subgroup analyses were performed. Twenty-four studies were eligible and they included 1120 subjects treated with TIPS and 1065 subjects treated with ET. Although there was no significant difference in survival and PTE, TIPS was superior to ET in decreasing the incidence of VRB (OR=0.27; 95% CI, 0.19–0.39, P<0.00001), and decreasing the incidence of bleeding-related death (OR=0.21; 95% CI, 0.13–0.32, P<0.00001). Subgroup analysis found a lower mortality (OR=0.48; 95% CI, 0.23–0.97; P=0.04) without any increased incidence of PTE (OR=1.37; 95% CI, 0.75–2.50; P=0.31) in the studies of a greater proportion (≥40%) of patients with Child-Pugh class C cirrhosis receiving TIPS, and TIPS with covered stent did not increase the risk of PTE compared to ET (OR=1.52, 95% CI =0.82–2.80, P=0.18). It was concluded that TIPS with covered stent might be considered the preferred choice of therapy in patients with severe liver disease for secondary prophylaxis.
Journal of Huazhong University of Science and Technology [Medical Sciences] – Springer Journals
Published: Aug 8, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.